-

Vizient Grants Public Access to the Vizient Vulnerability Index for Healthcare Providers to Assess Health Equity in their Communities

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced it is granting public access to the patent pending Vizient Vulnerability Index™. The access comes at no cost and provides a unique level of visibility for healthcare organizations to assess social determinants of health that impact health equity in the communities they serve. It is now available to anyone. Access the Vizient Vulnerability Index.

The Vizient Vulnerability Index aggregates 43 social determinants of health data points into nine categories at the local, regional and national levels that impact health outcomes. Each category of data quantifies how specific vulnerabilities impact specific populations. The public view provides zip code and Census tract-level information across these categories: Economic, education, healthcare access, neighborhood conditions, housing, clean environment, social environment, transportation and public safety.

“Many social determinants that impact communities extend beyond the hospital's walls, whether it's lack of housing, transportation or public safety,” said Beth Godsey, senior vice president, Data Science and Methodology for Vizient. “But knowing exactly what issues affect local residents gives health systems perspective on possible resources or partnerships necessary to better support those specific social needs.”

The Vizient Vulnerability Index aggregates the following public data sources:

  • American Community Survey 2020 (US Census) 5-year estimates survey data
  • USDA “food desert” measure of low-income population beyond a half mile (urban) or one mile (rural) from a grocery store
  • Environmental Protection Agency (EPA) data on air and water pollution
  • The Department of Housing and Urban Development’s (HUD) “severe housing cost” measure of housing cost burden over 50% of income

“Whatever the issue, clearcut data enables health systems to more effectively focus their interventions to mitigate challenges. The Vizient Vulnerability Index offers a new level of insight for healthcare organizations to understand their community and where gaps exist. Other indices simply don't allow for that same level of specificity,” Godsey said.

Learn more about Vizient’s data and analytics solutions.

About Vizient, Inc.

Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, serves more than 60% of the nation’s acute care providers, which includes 97% of the nation’s academic medical centers, and more than 25% of the non-acute care market. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient’s solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.

Contacts

Donna Ledbetter
(972) 830-6321
donna.ledbetter@vizientinc.com

Vizient, Inc.


Release Summary
Vizient announced today it is granting public access to the patent pending Vizient Vulnerability Index™. It is now available to anyone.
Release Versions

Contacts

Donna Ledbetter
(972) 830-6321
donna.ledbetter@vizientinc.com

Social Media Profiles
More News From Vizient, Inc.

Byron Jobe Recognized as One of Modern Healthcare’s 100 Most Influential People in Healthcare

IRVING, Texas--(BUSINESS WIRE)--This recognition acknowledges individuals who are deemed to be the most influential figures in the industry in terms of leadership and impact....

New Data Show Hospitals Continue to Improve Performance on Key Patient Safety Measures and Outcomes in 2025

WASHINGTON & IRVING, Texas--(BUSINESS WIRE)--Patient safety throughout health systems across the nation continue to improve, according to the American Hospital Association (AHA) and Vizient®....

Vizient Applauds FDA’s Recent Actions to Accelerate Biosimilar Development and Lower Costs

IRVING, Texas--(BUSINESS WIRE)--Vizient® commends the FDA for announcing actions to accelerate biosimilar development, including greater clarity for comparative efficacy studies....
Back to Newsroom